China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds ...

Recent federal actions could derail decades of progress. Meanwhile China has prioritized investment in biotech.

U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data ...

This is where Hong Kong's unique identity shines. As both part of China and a globally connected offshore market, it occupies ...

China's biotechnology sector is experiencing notable growth, with the ChinaAMC Hang Seng Biotech ETF, tracking the Hang Seng ...

Overall, this saw China-based biotech firms increase their market ... However, if the Chinese biotech sector is going to continue its growth trajectory, certain other aspects beyond investment ...

Shares to fall as Middle East tensions escalate; oil spikes above $US78.32; gold climbs. ASIC investigate ASX; Adnoc agrees ...

The recent uptick in the performance of A-share and Hong Kong-listed biotech stocks, particularly those related to innovative drugs, mirrors the trend toward a faster internationalization of China's ...

IN late May, workers of Zhejiang Yueli Electrical Co, a home appliances manufacturer based in Ningbo, Zhejiang province, were ...

Ernst made the remarks on the sidelines of the China-Swiss Companies Investment ... These partnerships will foster cross-border growth, as Beijing Dachao Biotechnology Co Ltd will invest and ...

Photo: Qu Dacheng, Vice Mayor of Chaoyang District, delivers remarks at the Global Investment Cooperation Trends Forum ...

The global genomics market, valued at US$42.4 billion in 2023, stood at US$42.6 billion in 2024 and is projected to advance ...